Intake Breathing Secures $62M Investment
Intake Breathing receives a $62 million investment from Camino Partners to expand distribution of its magnetic nasal dilator products.
A simple physical consumer product can still attract a sizable investment if its backers believe it can develop into a much larger wellness category. Intake Breathing is testing that thesis.
What happened
Intake Breathing secured $62 million from Camino Partners, marking its first major outside financing. The company sells magnetic nasal dilators intended to support airflow through the nose.
The business has built a consumer brand with users across fitness and wellness markets. New capital is expected to support broader retail distribution, marketing and expansion beyond its original customer segments.
The financing is not an AI round, a clinical trial result or a demonstration that the product treats particular medical conditions. Claimed benefits should be evaluated against evidence and product-specific limitations.
Why it matters
Consumer wellness markets can grow quickly through brand positioning, repeat purchases and distribution partnerships. But they also depend on trust and product efficacy: customers must experience enough value to sustain demand beyond novelty.
Unlike capital-light software businesses, Intake has to manage physical inventory, retail margins, manufacturing quality and channel partnerships.
The bigger picture
Venture investors continue to back category-creating consumer products alongside digital platforms. Intake's financing illustrates the importance of product positioning and distribution in markets where technological complexity is not necessarily the primary competitive advantage.